THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
Chapter 35 Psychological
factors and heart disease Susanne S. Pedersen, Nina Kupper, and Johan Denollet
References 1 De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003; 10: S1–S10. 2 De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601–10. 3 Yusuf S, Hawken S, Ounpuu S, Dans T, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937–52. 4 Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth joint task force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl.2): E1–E40. 5 Lichtman JH, Bigger JT, Jr., Blumenthal JA, et al. Depression and coronary heart disease. Recommendations for screening, referral, and treatment. A science advisory from the American Heart Association prevention committee of the council on cardiovascular nursing, council on clinical cardiology, council on epidemiology and prevention, and interdisciplinary council on quality of care and outcomes Research. Circulation 2008; 118: 1768–75. 6 Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol 2005; 45: 637–51. 7 Pedersen SS, Theuns DA, Erdman RA, et al. Clustering of devicerelated concerns and Type D personality predicts increased distress in ICD patients independent of shocks. Pacing Clin Electrophysiol 2008; 31: 20–7. 8 Thombs BD, De Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care. JAMA 2008; 300: 2161–71. 9 Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27: 2763–74.
2nd edition
10 APA. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition – Text Revision (DSM IV-TR), 2000. American Psychiatric Society. 11 Denollet J, Strik JJ, Lousberg R, et al. Recognizing increased risk of depressive comorbidity after myocardial infarction: looking for 4 symptoms of anxiety-depression. Psychother Psychosom 2006; 75: 346–52. 12 Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580–92. 13 Lane D, Carroll D, Ring C, et al. The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol 2002; 7: 11–21. 14 Pelle AJ, Gidron YY, Szabo BM, et al. Psychological predictors of prognosis in chronic heart failure. J Card Fail 2008; 14: 341–50. 15 Strik JJ, Honig A, Lousberg R, et al. Sensitivity and specificity of observer and self-report questionnaires in major and minor depression following myocardial infarction. Psychosomatics 2001; 42: 423–8. 16 Kop WJ, Appels AP, Mendes de Leon CF, et al. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56: 281–7. 17 Pedersen SS, Denollet J, Daemen J, et al. Fatigue, depressive symptoms, and hopelessness as predictors of adverse clinical events following percutaneous coronary intervention with paclitaxel-eluting stents. J Psychosom Res 2007; 62: 455–61. 18 Denollet J, Pedersen SS, Daemen J, et al. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. J Intern Med 2008; 263: 203–11. 19 de Jonge P, Ormel J, van den Brink RH, et al. Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis. Am J Psychiatry 2006; 163: 138–44. 20 Dickens C, McGowan L, Percival C, et al. Depression is a risk factor for mortality after myocardial infarction: fact or artifact?. J Am Coll Cardiol 2007; 49: 1834–40. 21 de Jonge P, van den Brink RH, Spijkerman TA, et al. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol 2006; 48: 2204–8. 22 Martens EJ, Denollet J, Pedersen SS, et al. Relative lack of depressive cognitions in post-myocardial infarction depression. J Affect Disord 2006; 94: 231–7. 23 Moser DK. “The rust of life”: impact of anxiety on cardiac patients. Am J Crit Care 2007; 16: 361–9. 24 Grace SL, Abbey SE, Irvine J, et al. Prospective examination of anxiety persistence and its relationship to cardiac symptoms and recurrent cardiac events. Psychother Psychosom 2004; 73: 344–52. 25 Strik JJ, Denollet J, Lousberg R, et al. Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 2003; 42: 1801–7. 26 Van den Broek KC, Nyklicek I, Van der Voort PH, et al. Shocks, personality, and anxiety in patients with an implantable defibrillator. Pacing Clin Electrophysiol 2008; 31: 850–7.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 1
7/17/2009 3:20:46 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
27 Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998; 97: 167–73. 28 Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008; 65: 62–71. 29 Moser DK, Riegel B, McKinley S, et al. Impact of anxiety and perceived control on in-hospital complications after acute myocardial infarction. Psychosom Med 2007; 69: 10–16. 30 Muller-Tasch T, Frankenstein L, Holzapfel N, et al. Panic disorder in patients with chronic heart failure. J Psychosom Res 2008; 64: 299–303. 31 Bull Bringager C, Arnesen H, Friis S, et al. A long-term follow-up study of chest pain patients: effect of panic disorder on mortality, morbidity, and quality of life. Cardiology 2008; 110: 8–14. 32 Spindler H, Pedersen SS, Elklit A. The role of posttraumatic stress disorder in coronary artery disease: Epidemiology, risk factors, and potential mechanisms. In Sher L (ed.) Psychological factors and cardiovascular disorders: The role of psychiatric pathology and maladaptive personality features, 2008. Hauppague, NY: Nova Science Publishers, Inc. 33 Spindler H, Pedersen SS. Posttraumatic stress disorder in the wake of heart disease: prevalence, risk factors, and future research directions. Psychosom Med 2005; 67: 715–23. 34 Gander ML, von Känel R. Myocardial infarction and post-traumatic stress disorder: frequency, outcome, and atherosclerotic mechanisms. Eur J Cardiovasc Prev Rehabil 2006; 13: 165–72. 35 Ladwig KH, Baumert J, Marten-Mittag B, et al. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry 2008; 65: 1324–30. 36 Shemesh E, Yehuda R, Milo O, et al. Posttraumatic stress, nonadherence, and adverse outcome in survivors of a myocardial infarction. Psychosom Med 2004; 66: 521–6. 37 Mookadam F, Arthur HM. Social support and its relationship to morbidity and mortality after acute myocardial infarction: systematic overview. Arch Intern Med 2004; 164: 1514–8. 38 Ruberman W, Weinblatt E, Goldberg JD, et al. Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1984; 311: 552–9. 39 Denollet J, Pedersen SS, Ong AT, et al. Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era. Eur Heart J 2006; 27: 171–7. 40 Berry JD, Lloyd-Jones DM, Garside DB, et al. Social avoidance and long-term risk for cardiovascular disease death in healthy men: the Western Electric study. Ann Epidemiol 2007; 17: 591–6. 41 Sapolsky RM, Alberts SC, Altmann J. Hypercortisolism associated with social subordinance or social isolation among wild baboons. Arch Gen Psychiatry 1997; 54: 1137–43. 42 Seeman TE, Berkman LF, Blazer D, et al. Social ties and support and neuroendocrine functions: the Macarthur studies of successful aging. Ann Behav Med 1994; 16: 95–106.
2nd edition
43 Rumsfeld JS. Health status and clinical practice: when will they meet?. Circulation 2002; 106: 5–7. 44 Spertus JA. Evolving applications for patient-centered health status measures. Circulation 2008; 118: 2103–10. 45 Krumholz HM, Peterson ED, Ayanian JZ, et al. Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease. Circulation 2005; 111: 3158–66. 46 O‘Brien JL, Moser DK, Riegel B, et al. Comparison of anxiety assessments between clinicians and patients with acute myocardial infarction in cardiac critical care units. Am J Crit Care 2001; 10: 97–103. 47 Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User’s Manual, 2nd edn., 1994. Boston, MA: The Health Institute, New England Medical Center. 48 Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995; 25: 333–41. 49 Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation 2002; 106: 43–9. 50 Mommersteeg PMC, Denollet J, Spertus JA, et al. Health status as a risk factor in cardiovascular disease: A systematic review of current evidence. Am Heart J 2009; 157: 208–18. 51 Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38: 199–205. 52 Rumsfeld JS, Magid DJ, Plomondon ME, et al. Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia. J Am Coll Cardiol 2003; 41: 1732–8. 53 Smith TW, MacKenzie J. Personality and risk of physical illness. Annu Rev Clin Psychol 2006; 2: 435–67. 54 Razzini C, Bianchi F, Leo R, et al. Correlations between personality factors and coronary artery disease: from type A behaviour pattern to Type D personality. J Cardiovasc Med 2008; 9: 761–8. 55 Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: A meta-analytic review of prospective evidence. J Am Coll Cardiol 2009; 53: 936–46. 56 Denollet J, Sys SU, Stroobant N, et al. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996; 347: 417–21. 57 Steptoe A, Molloy GJ. Personality and heart disease. Heart 2007; 93: 783–4. 58 Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med 2005; 67: 89–97. 59 Pedersen SS, Denollet J. Is Type D personality here to stay? Emerging evidence across cardiovascular disease patient groups. Curr Cardiol Rev 2006; 2: 205–13. 60 Denollet J, de Jonge P, Kuyper A, et al. Depression and Type D personality represent different forms of distress in the Myocardial INfarction and Depression – Intervention Trial (MIND-IT). Psychol Med 2009; 39: 749–56.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 2
7/17/2009 3:20:46 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
61 Schiffer AA, Pedersen SS, Widdershoven JW, et al. Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure. Eur J Heart Fail 2008; 10: 802–10. 62 Al-Ruzzeh S, Athanasiou T, Mangoush O, et al. Predictors of poor mid-term health related quality of life after primary isolated coronary artery bypass grafting surgery. Heart 2005; 91: 1557–62. 63 Denollet J, Vaes J, Brutsaert DL. Inadequate response to treatment in coronary heart disease: adverse effects of Type D personality and younger age on 5-year prognosis and quality of life. Circulation 2000; 102: 630–5. 64 Schiffer AA, Pedersen SS, Widdershoven JW, et al. The distressed (Type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure. Eur J Cardiovasc Prev Rehabil 2005; 12: 341–6. 65 Pedersen SS, Holkamp PG, Caliskan K, et al. Type D personality is associated with impaired health-related quality of life 7 years following heart transplantation. J Psychosom Res 2006; 61: 791–5. 66 Pedersen SS, Theuns DAMJ, Muskens-Heemskerk A, et al. Type D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation. Europace 2007; 9: 675–80. 67 Aquarius AE, Denollet J, Hamming JF, et al. Role of disease status and Type D personality in outcomes in patients with peripheral arterial disease. Am J Cardiol 2005; 96: 996–1001. 68 Aquarius AE, Denollet J, Hamming JF, et al. Type D personality and ankle brachial index as predictors of impaired quality of life and depressive symptoms in peripheral arterial disease. Arch Surg 2007; 142: 662–7. 69 Aquarius AE, Denollet J, de Vries J, et al. Poor health-related quality of life in patients with peripheral arterial disease: Type D personality and severity of peripheral arterial disease as independent predictors. J Vasc Surg 2007; 46: 507–12. 70 Pedersen SS, Denollet J, Ong AT, et al. Impaired health status in Type D patients following PCI in the drug-eluting stent era. Int J Cardiol 2007; 114: 358–65. 71 Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med 2006; 21: 30–8. 72 Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161: 1849–56. 73 van Melle JP, de Jonge P, Spijkerman TA, et al. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 2004; 66: 814–22. 74 Rumsfeld JS, Havranek E, Masoudi FA, et al. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42: 1811–17. 75 Muller-Tasch T, Peters-Klimm F, Schellberg D, et al. Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. J Card Fail 2007; 13: 818–24.
2nd edition
76 DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: metaanalysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–17. 77 Lespérance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med 2000; 160: 1354–60. 78 Blumenthal JA, Lett HS, Babyak MA, et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 2003; 362: 604–9. 79 Parashar S, Rumsfeld JS, Spertus JA, et al. Time course of depression and outcome of myocardial infarction. Arch Intern Med 2006; 166: 2035–43. 80 Dickens C, McGowan L, Percival C, et al. New onset depression following myocardial infarction predicts cardiac mortality. Psychosom Med 2008; 70: 450–5. 81 Cherr G, Zimmerman P, Wang J, et al. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization. J Gen Int Med 2008; 23: 629–34. 82 Parissis JT, Nikolaou M, Farmakis D, et al. Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart 2008; 94: 585–9. 83 Whang W, Albert CM, Sears SF, Jr., et al. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am Coll Cardiol 2005; 45: 1090–5. 84 Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66: 802–13. 85 Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006; 48: 1527–37. 86 Januzzi JL, Jr., Stern TA, Pasternak RC, et al. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000; 160: 1913–21. 87 Lane D, Carroll D, Ring C, et al. Mortality and quality of life 12 months after myocardial infarction: effects of depression and anxiety. Psychosom Med 2001; 63: 221–30. 88 Tully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res 2008; 64: 285–90. 89 Pedersen SS, Denollet J, Spindler H, et al. Anxiety enhances the detrimental effect of depressive symptoms on health status following percutaneous coronary intervention. J Psychosom Res 2006; 61: 783–9. 90 Empana JP, Jouven X, Lemaitre R, et al. Marital status and risk of out-of-hospital sudden cardiac arrest in the population. Eur J Cardiovasc Prev Rehabil 2008; 15: 577–82. 91 Molloy GJ, Hamer M, Randall G, et al. Marital status and cardiac rehabilitation attendance: a meta-analysis. Eur J Cardiovasc Prev Rehabil 2008; 15: 557–61. 92 Steinberg JS, Joshi S, Schron EB, et al. Psychosocial status predicts mortality in patients with life-threatening ventricular arrhythmias. Heart Rhythm 2008; 5: 361–5.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 3
7/17/2009 3:20:46 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
93 Denollet J, Martens EJ, Nyklicek I, et al. Clinical events in coronary patients who report low distress: adverse effect of repressive coping. Health Psychol 2008; 27: 302–8. 94 Pedersen SS, Lemos PA, van Vooren PR, et al. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol 2004; 44: 997–1001. 95 Pedersen SS, Denollet J, Ong AT, et al. Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. Eur J Cardiovasc Prev Rehabil 2007; 14: 135–40. 96 Denollet J, Holmes RV, Vrints CJ, et al. Unfavorable outcome of heart transplantation in recipients with Type D personality. J Heart Lung Transplant 2007; 26: 152–8. 97 Aquarius AE, Smolderen KG, Hamming JF, et al. Type D personality predicts mortality in peripheral arterial disease: A pilot study. Arch Surg, in press. 98 Chapman BP, Duberstein PR, Lyness JM. The Distressed personality type: replicability and general health associations. Eur J Pers 2007; 21: 911–29. 99 Denollet J, Pedersen SS. Prognostic value of Type D personality compared with depressive symptoms. Arch Intern Med 2008; 168: 431–2. 100 de Jonge P, Denollet J, van Melle JP, et al. Associations of Type D personality and depression with somatic health in myocardial infarction patients. J Psychosom Res 2007; 63: 477–82. 101 Pelle AJ, Erdman RA, van Domburg RT, et al. Type D patients report poorer health status prior to and after cardiac rehabilitation compared to non-Type D patients. Ann Behav Med 2008; 36: 167–75. 102 Scherer M, Stanske B, Wetzel D, et al. [Psychosocial co-symptoms in primary care patients with heart failure]. Herz 2006; 31: 347–54. 103 Martens EJ, Kupper N, Pedersen SS, et al. Type D personality is a stable taxonomy in post-MI patients over an 18-month period. J Psychosom Res 2007; 63: 545–50. 104 Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87–92. 105 Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289: 3106–16. 106 Glassman AH, O‘Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002; 288: 701–9. 107 Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, Type 2 diabetes and stroke. J Int Med 2000; 247: 188–97. 108 Lett HS, Blumenthal JA, Babyak MA, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66: 305–15. 109 Molloy GJ, Perkins-Porras L, Strike PC, et al. Type D personality and cortisol in survivors of acute coronary syndrome. Psychosom Med 2008; 70: 863–8.
2nd edition
110 Whitehead DL, Perkins-Porras L, Strike PC, et al. Cortisol awakening response is elevated in acute coronary syndrome patients with Type D personality. J Psychosom Res 2007; 62: 419–25. 111 Sandercock GRH, Brodie DA. The role of heart rate variability in prognosis for different modes of death in chronic heart failure. Pacing Clin Electrophysiol 2006; 29: 892–904. 112 Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99: 2192–217. 113 Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation 2001; 104: 2024–8. 114 de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul study. Psychosom Med 2007; 69: 735–9. 115 Carney RM, Blumenthal JA, Freedland KE, et al. Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med 2005; 165: 1486–91. 116 Watkins LL, Blumenthal JA, Carney RM. Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. Am Heart J 2002; 143: 460–6. 117 Piccirillo G, Viola E, Nocco M, et al. Autonomic modulation and QT interval dispersion in hypertensive subjects with anxiety. Hypertension 1999; 34: 242–6. 118 Carney RM, Freedland KE, Stein PK, et al. Effects of depression on QT interval variability after myocardial infarction. Psychosom Med 2003; 65: 177–80. 119 Nahshoni E, Gur S, Marom S, et al. QT dispersion in patients with social phobia. J Affect Disord 2004; 78: 21–6. 120 Minoretti P, Politi P, Martinelli V, et al. QT interval duration in apparently healthy men is associated with depressionrelated personality trait neuroticism. J Psychosom Res 2006; 61: 19–23. 121 Smith PJ, Blumenthal JA, Babyak MA, et al. Ventricular ectopy: impact of self-reported stress after myocardial infarction. Am Heart J 2007; 153: 133–9. 122 von Känel R. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?. Acta Psychiatr Scand 2004; 110: 163–77. 123 Aschbacher K, Mills PJ, von Känel R, et al. Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers. Brain Behav Immun 2008; 22: 493–502. 124 Somberg TC, Arora RR. Depression and heart disease: therapeutic implications. Cardiology 2008; 111: 75–81. 125 Oosthuizen F, Wegener G, Harvey BH. Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model. Neuropsychiatr Dis Treat 2005; 1: 109–23. 126 Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054–9.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 4
7/17/2009 3:20:46 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
127 Broadley AJ, Korszun A, Jones CJ, et al. Arterial endothelial function is impaired in treated depression. Heart 2002; 88: 521–3. 128 Sherwood A, Hinderliter AL, Watkins LL, et al. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol 2005; 46: 656–9. 129 von Känel R, Hepp U, Traber R, et al. Measures of endothelial dysfunction in plasma of patients with posttraumatic stress disorder. Psychiatry Res 2008; 158: 363–73. 130 Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–43. 131 Sukhija R, Fahdi I, Garza L, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007; 99: 879–84. 132 Denollet J, Schiffer AA, Kwaijtaal M, et al. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure. Am J Cardiol 2009; 103: 399–404. 133 Strike PC, Steptoe A. Systematic review of mental stress-induced myocardial ischaemia. Eur Heart J 2003; 24: 690–703. 134 Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118: 397–409. 135 Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or Takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006; 27: 1523–9. 136 Kupper N, Denollet J, de Geus EJC, et al. Heritability of Type D personality. Psychosom Med 2007; 69: 675–81. 137 Middeldorp CM, Birley AJ, Cath DC, et al. Familial clustering of major depression and anxiety disorders in Australian and Dutch twins and siblings. Twin Res Hum Genet 2005; 8: 609–15. 138 McCaffery JM, Frasure-Smith N, Dube M-P, et al. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom Med 2006; 68: 187–200. 139 DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101–7. 140 Broström A, Strömberg A, Mårtensson JAN, et al. Association of Type D personality to perceived side effects and adherence in CPAP-treated patients with OSAS. J Sleep Res 2007; 16: 439–47. 141 Marcuccio E, Loving N, Bennett SK, et al. A survey of attitudes and experiences of women with heart disease. Women’s Health Issues 2003; 13: 23–31. 142 Schiffer AA, Denollet J, Widdershoven JW, et al. Failure to consult for symptoms of heart failure in patients with a Type D personality. Heart 2007; 93: 814–8. 143 Lane D, Carroll D, Ring C, et al. Predictors of attendance at cardiac rehabilitation after myocardial infarction. J Psychosom Res 2001; 51: 497–501. 144 Grace SL, Gravely-Witte S, Brual J, et al. Contribution of patient and physician factors to cardiac rehabilitation enrollment: a prospective multilevel study. Eur J Cardiovasc Prev Rehabil 2008; 15: 548–56.
2nd edition
145 Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) Trial. JAMA 2007; 297: 367–79. 146 van Melle JP, de Jonge P, Honig A, et al. Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry 2007; 190: 460–6. 147 Denollet J, Pedersen SS, Vrints CJ, et al. Usefulness of Type D personality in predicting five-year cardiac events above and beyond concurrent symptoms of stress in patients with coronary heart disease. Am J Cardiol 2006; 97: 970–3. 148 Appels A, Bar F, van der Pol G, et al. Effects of treating exhaustion in angioplasty patients on new coronary events: results of the randomized Exhaustion Intervention Trial (EXIT). Psychosom Med 2005; 67: 217–23. 149 Pedersen SS, Van den Broek KC, Sears J, et al. Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 2007; 30: 1546–54. 150 Carney RM, Blumenthal JA, Freedland KE, et al. Depression and Late Mortality After Myocardial Infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) Study. Psychosom Med 2004; 66: 466–74. 151 van Dixhoorn J, White A. Relaxation therapy for rehabilitation and prevention in ischaemic heart disease: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2005; 12: 193–202. 152 Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J 2007; 28: 2972–84. 153 Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of Exercise and Stress Management Training on Markers of Cardiovascular Risk in Patients With Ischemic Heart Disease: A Randomized Controlled Trial. JAMA 2005; 293: 1626–34. 154 Moravec CS. Biofeedback therapy in cardiovascular disease: rationale and research overview. Cleve Clin J Med 2008; 75(Suppl.2): S35–S38. 155 Denollet J, Brutsaert DL. Reducing emotional distress improves prognosis in coronary heart disease: 9-year mortality in a clinical trial of rehabilitation. Circulation 2001; 104: 2018–23. 156 Culic V, Eterovic D, Miric D, et al. Triggering of ventricular tachycardia by meteorologic and emotional stress: protective effect of beta-blockers and anxiolytics in men and elderly. Am J Epidemiol 2004; 160: 1047–58. 157 Thombs BD, Ziegelstein RC, Whooley MA. Optimizing detection of major depression among patients with coronary artery disease using the Patient Health Questionnaire: data from the Heart and Soul study. J Gen Intern Med 2008; 23: 2014–7. 158 Beck AT, Steer RA, Garbin MC. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev 19998; 8: 77–100. 159 Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 5
7/17/2009 3:20:46 PM
THE ESC TEXTBOOK OF CARDIOVASCULAR MEDICINE
160 Albus C, Jordan J, Herrmann-Lingen C. Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice. Eur J Cardiovasc Prev Rehabil 2004; 11: 75–9. 161 Poston WS, Haddock CK, Conard MW, et al. Assessing depression in the cardiac patient. When is the appropriate
2nd edition
time to assess depression in the patient undergoing coronary revascularization? Behav Modif 2003; 27: 26–36. 162 Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008; 359: 677–87.
© 2009 The European Society of Cardiology
Camm-Chap-35-Ref.indd 6
7/17/2009 3:20:46 PM
